Again, TRAIL also seemingly shows a Janus-faced nature as, on the one side, it has been linked to muscle fiber damage in conditions of inflammatory myopathies [71] but also has been shown capable of reducing inflammation, improving insulin responsiveness, and attenuating metabolic abnormalities in diabetes [72,73]. The gene discussed is INS; the disease is myopathy.